Telangiectasia

• FDA approval · 2025-01-30
  FDA Approved: ASCLERA — Supplemental Application (Methapharm, Inc)

  FDA approved a supplemental application for ASCLERA (polidocanol) submitted by Methapharm, Inc.

• FDA approval · 2010-03-30
  FDA Approved: ASCLERA — Original Application (Methapharm, Inc)

  FDA approves ASCLERA (polidocanol) for sclerotherapy to treat varicose veins and related superficial venous conditions.